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Reliability and validity of a global question on self-reported chronic morbidity  
 
Abstract 
 
Aim: 
A global question on chronic morbidity is included in many national health interview 
surveys. According to a recent EU Commission regulation, information on this item should 
be collected in all EU member states. However, little is known about the reliability and 
validity of such a question.  
Subject and methods: 
The reliability of a global question on chronic morbidity was investigated among persons 
who participated in 2001 both in the Belgian health interview survey (HIS) and the national 
population census (n = 2,871), by using kappa statistics and logistic regression.  
In addition, data from the HIS 2001 and 2004 (n = 21,376) were used to study estimates and 
determinants of the sensitivity of this global chronic morbidity measure among people with 
specific chronic diseases. 
Results: 
In terms of reliability, the kappa statistic showed only a moderate agreement (0.559; 95% CI 
0.523-0.594).  
Additionally, the sensitivity of the global question on chronic morbidity ranged from 49.9 to 
87.2%, depending on the type of disease. A much higher sensitivity was observed among 
people who rated their health status to be moderate to bad (adjusted OR 3.85; 95% CI 3.17-
4.69). 
Conclusion: 
Self-reported chronic morbidity, measured by a single and global question, is a reasonably 
reliable instrument to measure ill health. The global instrument provides useful information 
on the burden of disease, because it takes into account the relevance of the diseases for the 
people themselves.  
 
Keywords: chronic disease, validity, reliability, health interview survey 
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Introduction 
 
Chronic diseases are the largest cause of death in the world and contribute substantially to 
the burden of disability (Murray et al. 2012). Moreover, deaths from chronic diseases are 
projected to increase dramatically between now and 2030 (Mathers et al. 2006). Chronic 
diseases have a significant impact on the quality of life of those affected and their families 
and are a major driver of health care costs, especially in case of multimorbidity. 
 
To describe the burden of disease, calculate health indicators which measure life expectancy 
in relation to health status, and assess differences in ill health between population groups, 
there is a need for concise, population-based information on the prevalence of chronic 
morbidity. This information can most easily be collected through one global question in a 
population survey. An example of such question is: “Do you suffer from any chronic illness 
or condition?”. This question is part of the Minimum European Health Module (MEHM), an 
instrument developed in the framework of the Euro-REVES project, with global questions on 
perceived health, chronic morbidity and activity limitation. The MEHM is included in the 
European Survey on Income and Living Conditions (EU-SILC) and the European Health 
Interview Survey (EHIS). The module allows collecting information on items for which 
according to an EU Commission Regulation1, European member states are bound to provide 
data to Eurostat. Even though the EHIS regulation was only published in February 2013, 
global questions on chronic morbidity have been used in many national health surveys in 
Europe well before (Aromaa et al. 2003). In the UK, a global question on chronic morbidity 
has been included in the General Household Survey (GHS) since 1971 (Macintyre et al. 
2005). In Belgium, information on this item has been collected since the first national Health 
Interview Survey in 1997 (Demarest et al. 2013).  
 
The most straightforward indicator that is derived from such a global question is the 
prevalence of self-reported chronic morbidity. This indicator has been included in the 
shortlist of the European Core Health Indicators (ECHI), which is a comprehensive list of 
public health indicators at the EU level (Verschuuren et al. 2013). Another indicator based 
                                                          
1
 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2013:047:0020:0048:EN:PDF 
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on this question is life expectancy with and without chronic morbidity. The algorithm to 
calculate this indicator is based on the Sullivan method (Sullivan 1971) and was developed 
by Eurostat in collaboration with the European Health Expectancy Monitoring Unit 
(EHEMU). EU-SILC data have been used to calculate the prevalence of chronic morbidity and 
life expectancy with and without chronic morbidity in 25 EU member states (Jagger et al. 
2008). 
 
Although the validity and reliability of self-reported health status measures have been 
studied extensively, up to now most research has focused on self-rated health. This concept, 
which is measured with the question, “How do you rate your health in general?”, appears to 
be an excellent predictor of mortality, morbidity, functional status, disability, and health 
consumption (de Bruin et al. 1996). Furthermore, several studies have assessed the validity 
of specific self-reported chronic diseases (Martin et al. 2000). The results depend on the 
type of disease; a specificity of 90% or higher is found for self-reported diabetes, 
hypertension, stroke, cancer, and asthma (Engstad et al. 2000; Fowles et al. 1998); in 
contrast, for self-reported arthritis, hypothyroidism, hyperthyroidism and acne the 
specificity is less than 75% (Bombard et al. 2005; Brix et al. 2001; Menon et al. 2008). 
 
Compared to the question on self-rated health, the global question to measure self-
reported chronic morbidity has far less been studied. Conceptual work has been done by 
Robine et al. (2002) and Burata et al. (2003). Cox et al. (2009) assessed the reliability of the 
MEHM in a small sample. However, to date, no large scale studies are available that 
investigate both the reliability and validity of a global question on chronic morbidity at 
population level. 
 
Therefore, the main aim of this study was to assess the reliability and validity of a global 
question on self-reported chronic morbidity within a large and representative sample of the 
general population. An additional aim was to investigate to which extent the reliability and 
validity of this question varied in function of socio-demographic and interview-related 
background characteristics. 
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Methods  
 
Data 
 
In Belgium, national health interview surveys (HIS) have been organised periodically since 
1997, with intervals varying between 3 and 5 years. For this study, data were used from the 
respondents, aged 15 years and older, participating in the HIS 2001 (n = 10,156) and the 
HIS 2004 (n =11,220).  The HIS 2001 and the HIS 2004 are independent cross sectional 
surveys. The sampling frame is the national register. The probability that the same person is 
selected for both surveys is negligible (approximately 1/1,000,000). 
 
In the HIS, information is collected on the health status, the life style, and the health care 
utilization of a representative sample of the total Belgian population. The face to face 
questionnaire includes a global question on chronic morbidity. The exact formulation of this 
question is: “Do you have a longstanding disease, condition or handicap? (yes/no)”. This 
question differs from the question in the MEHM, because at the time the first health survey 
was conducted in Belgium in 1997, the MEHM question was not yet available. To be able to 
follow time trends, the original question has been consistently used in all consecutive health 
surveys.  
 
The same question was also included in the national Belgian population census of 2001. 
Participation in the census was mandatory for all Belgian residents (n = 10,263,414). For the 
respondents, aged 15 years and older, who participated between September 2001 and 
January 2002 both in the HIS and the census (n = 2,871), an individual data linkage was 
performed between the HIS 2001 data and the answer to the global question on chronic 
morbidity in the census, using the National Population Register ID as key variable.  
 
Three types of variables were identified as potential determinants of the reliability and 
validity of self-reported chronic morbidity: 1) socio-demographic variables (gender, age, 
educational attainment, nationality); 2) health-related variables (type and number of 
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specific self-reported chronic diseases, self-rated health, mental health); and 3) an 
interview-related variable (self-reporting versus proxy-interview).  
 
Educational attainment was defined at the level of the household. Information on specific 
chronic diseases and conditions was obtained by asking if the person had suffered from that 
particular disease during the twelve months preceding the survey. Mental health was 
measured through the General Health Questionnaire (GHQ) (Goldberg et al. 1988), in its 
short version (GHQ-12). This questionnaire assesses the notion of “general sufferance as 
unique and global morbid class”, i.e. psychological distress. A score of 4 or more indicates 
the presence of psychological problems, probably calling for professional help. The 
indicators on mental health and self-rated health were based on questions in the self-
administered questionnaire. Therefore, no information on those indicators was available for 
respondents for whom the information was collected via a proxy-interview (5.9% of 
respondents), because for those interviews it was not authorised to complete a self-
administered questionnaire. 
 
Analysis 
 
For the respondents who participated both in the HIS and the census, the reliability of the 
answer to the question “Do you have a long standing disease, condition or handicap?” 
between HIS and census was investigated via kappa statistics. Determinants of responding 
inconsistently were assessed through logistic regression.   
 
For the validity calculations, combined data of the HIS2001 and the HIS2004 were used. In 
the assessment of the validity of an instrument, different aspects can be considered: 
content validity, face validity, correlational validity and criterion validity (McDowell et al. 
1996). Criterion validity considers whether the instrument correlates highly with a “gold 
standard”. This was the approach followed in the current study, with having a specific 
chronic disease as a “gold standard”. In a first step, a selection was made of specific chronic 
diseases included in the HIS, for which self-reported information was estimated to be 
sufficiently accurate. This was assessed by searching PubMed, Embase and Scopus for 
studies published until January 2013, using the following search strategy: "self-report" AND 
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“validity” AND “(morbidity OR disease)” AND “survey”. This search strategy yielded 2001 
references. Based on the title, and if the title alone was not sufficient, the abstract, 41 
articles were retrieved and full-text screened. In 27 papers results were reported on the 
specificity of one or more self-reported chronic diseases which were included in the list of 
diseases in the HIS questionnaire. Chronic diseases were eligible for inclusion if literature 
findings were available that pointed out that the specificity of self-reported information for 
that disease, defined as the number of true negatives divided by the number of true 
negatives and false positives, was at least 80%, using medical records or clinical 
measurements as gold standard.  For the sensitivity analyses we focused on respondents 
with at least one of the selected specific chronic diseases. A true positive was defined as a 
person who had responded positively to the global question on chronic morbidity, a false 
negative a person who had answered negatively to this question; the sensitivity was then 
calculated as the true positives divided by the true positives and the false negatives. In a 
final step, a multivariate analysis was performed to verify if the sensitivity varied 
significantly in function of potential determinants. Information on self-rated and mental 
health, which was collected via a  self-administered questionnaire, was not available for 
respondents who were interviewed via a proxy. Therefore proxy interviews (n = 112) were 
excluded from the multivariate analyses. 
 
All analyses were carried out with Stata/SE  10.1 (StataCorp, College Station, Texas). 
Estimates and standard errors were calculated, taking into account the stratified, clustered 
sampling design of the HIS.  
 
Results 
 
General agreement HIS – census 
 
Among the 2,871 respondents who participated in the last quarter of 2001 both in the HIS 
and the census, the prevalence of self-reported chronic morbidity was 28.4% (95% CI 25.9-
30.9%) according to the HIS and 26.3% (95% CI 23.6-29.2%) according to the census 
(Table 1). A discordant result was found in 469 (18.2%) of the 2,626 participants for whom 
valid information on the global question of chronic morbidity was available in both data 
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sources. Accordingly, the kappa statistic showed only a moderate agreement (0.559; 95% CI 
0.523-0.594).  
 
PLEASE INSERT TABLE 1 HERE  
 
Results by gender, age, self-rated health, GHQ-score, education, nationality, and type of  
respondent (Table 1) revealed that the reliability did not vary a lot by subgroup, except 
among persons with a GHQ-score of 4 or more (kappa 0.631;95% CI 0.596-0.667), who 
showed a substantially higher reliability than persons with a GHQ-score between 0 and 3 
(kappa  0.526;95% CI 0.488-0.565). Non-Belgian citizens (kappa 0.417;95% CI 0.379-0.456) 
showed a substantially lower reliability than Belgians ones (kappa 0.574;95% CI 0.539-
0.609).  
 
In a multivariate analysis, investigating the discrepancy between HIS and population census, 
only age came out as a significant factor (Table 2). An increasing age was clearly associated 
with a higher discrepancy of the results. The odds ratio for the age group of 65 years and 
older was 2.57 (95% CI 1.29-5.12), compared to the reference category of 15-24 years.  
Neither mental health, nor self-rated health appeared to have an impact on the reliability of 
self-reported chronic morbidity.   
 
PLEASE INSERT TABLE 2 HERE  
 
Disease-specific consistency in reporting 
 
From the literature findings, it appeared that for ten specific chronic diseases which were 
included in the HIS, the specificity of self-reported prevalence compared to clinical 
measurement or medical records was at least 80%: asthma, hypertension, serious heart 
disease or heart attack, stroke, diabetes mellitus, epilepsy, Parkinson’s disease, cataract, 
glaucoma, and malignant neoplasm or cancer. The outcome of the literature review is 
presented more in detail in Table 3.  
 
PLEASE INSERT TABLE 3 HERE  
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The sensitivity of the global chronic morbidity measure in the combined data of the HIS 
2001 and the HIS 2004 ranged from 49.9% (95% CI 47.3-52.6%) among people with 
hypertension to 87.2 (95% CI 72.0-94.7%) among people with Parkinson’s disease (Table 4), 
and was for each disease substantially higher for people who consider their health to be 
moderate or bad than for those who consider themselves to be in good health. 
 
PLEASE INSERT TABLE 4 HERE  
 
Figure 1 shows the increase of the sensitivity of the global chronic morbidity measure in 
function of the number of reported diseases. If one disease was reported, the sensitivity 
was 52.3% in men and 53.2% in women. In case of three reported diseases, the sensitivity 
was around 80%. Only from the presence of 5 diseases in women and 6 diseases in men 
onwards, the sensitivity was 100%.  
 
PLEASE INSERT FIGURE 1 HERE  
 
Unlike the reliability, the sensitivity of the global chronic morbidity measure varied far more 
in function of background characteristics (Table 5). The sensitivity was significantly higher in 
people indicating that their subjective health was moderate to bad (OR 3.85; 95% CI 3.17-
4.69 compared to those estimating their health to be good to very good). It was significantly 
lower in non-Belgians (OR 0.60; 95%CI 0.41-0.86 compared to Belgians). Diseases that were 
strongly associated with a higher sensitivity were epilepsy, stroke, cancer, asthma, diabetes, 
and serious heart disease or heart attack. Also a GHQ-score of 4 or more was significantly 
associated with a higher sensitivity (OR 1.34; 95% CI 1.02-1.75 compared to those with a 
GHQ below 4).  
 
PLEASE INSERT TABLE 5 HERE  
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Discussion 
According to criteria proposed by Landis et al. (1977), the overall kappa value of the global 
question on self-reported chronic morbidity in this study is moderate, and lower than 
expected, especially in comparison with the results from Cox et al. (2009) or those from an 
Australian study assessing the reliability of self-reported specific chronic conditions (Dal 
Grande et al. 2012). The relatively low reliability may be related to the difference in the 
mode of data collection between the HIS and the population census. In survey methodology, 
it is well known that the quality of the data is affected by the mode of the data collection 
(Groves et al. 2004).  Whereas in the HIS, data were collected via a face to face interview, 
census information was initially collected via a postal survey, and only in case of non-
response an interviewer visited the respondent for a face to face interview. Other 
methodological reasons why people may have answered in a discordant way could be: 
differences in the focus of the survey (health versus socio-economic information), the length 
of the questionnaire, and the mandatory nature of the census. The difference in  the mode 
of the data collection between the HIS and the census may also have affected the results on 
the discrepancy in self-reported chronic morbidity in function of background characteristics, 
which are presented in Table 2. This is e.g. possible if the impact of the mode of the data 
collection is more important for one population group than for another. 
 
In international comparisons of survey results, the impact of the data collection mode, 
which is assumed to be a major explanatory factor of the relatively low reliability in our 
study, is often insufficiently considered. During the last decade, both WHO and Eurostat 
have done major efforts for the harmonization of instruments in health surveys at the 
European level. Nevertheless, it is unfortunate that in the current EU Commission EHIS 
regulation, no guidelines are included on the exact formulation of the questions, nor on the 
data collection mode. Not only this under valorises the huge amount of preparatory work 
that has been done in the field of pre-harmonisation of the questions, but also it jeopardises 
substantially the international comparability of the data that are submitted to Eurostat, 
including those on self-reported chronic morbidity. 
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The sensitivity of the global chronic morbidity measure depends strongly on the type of 
specific disease. The impact of a disease, in terms of symptoms and effect on the daily living, 
may substantially affect the people’s judgment on whether they consider themselves to 
have a chronic disease or not. This may explain why only half of the patients with 
hypertension, which often presents without any symptoms, report to have a chronic disease 
via the global question. 
 
Although the analyses were restricted to diseases for which there is evidence in the 
literature that self-reports are sufficiently valid, the use of self-reported information as gold 
standard is definitely a weakness. Also the assumption that self-reported information is 
valid when it is confirmed by medical records or clinical measurements may not be 
completely true. The information from medical records may be incomplete and clinical 
measurements may vary over time. However, in the absence of more objective information, 
the use of self-reported chronic diseases as gold standard was the best option that could be 
taken. Another weakness is that the specificity of the global question could not be tested, 
because the information on specific chronic diseases in the HIS is not exhaustive. Hence, it 
was not possible to identify false positives, i.e. persons answering positively to the global 
question on chronic morbidity without having a specific chronic disease.  
 
An important strength of this study is that it was conducted in a large, representative 
sample of the total population. Seasonal effects, which could have affected the results on 
the reliability were avoided by including only persons who participated, within the same 
period of four months, both to the census and the HIS. Proxy-interviews were included as 
well. It is remarkable that the reliability of self-reported chronic morbidity was quite similar 
for respondents who answered themselves and via proxy-respondents. However, this result 
should be interpreted with caution. The number of proxy-respondents was low, and the 
impact of a proxy-interview could not be adjusted for subjective and mental health, because 
for those respondents no self-administered questionnaire was available.  
 
Some determinants of the validity and reliability of self-reported chronic morbidity appear 
to be the same as those identified in studies assessing the reliability and validity of self-
rated health. This applies for age (Crossley et al. 2002; Zajacova et al. 2011) and nationality 
11 
 
(Bombak et al. 2012), and to some extent to gender (Deeg et al. 2003).  A higher age is 
associated with a lower reliability, but not with a different validity. Nationality has no impact 
on the reliability, but among respondents with one or more specific chronic diseases non-
national citizens answer significantly less often positively to the global question on chronic 
disease. The sensitivity of the global chronic morbidity measure is also lower in women than 
in men. Perhaps the perception on what is a chronic disease may vary among different 
population groups. After adjustment for age, gender and nationality, our study did not point 
out any educational differences. Our data thus support the hypothesis that a global question 
in a health survey is suitable to estimate socioeconomic status gradients in chronic 
morbidity, which is in line with the findings of Macintyre et al. (2005). 
 
Although chronic diseases include essentially cardiovascular diseases, cancer, chronic 
respiratory diseases and diabetes (Horton 2005), this list is not exhaustive (Piot et al. 2010) 
and especially lay people might interpret this arbitrarily. Still, it is reassuring that a strong, 
significant and independent association was found between the global question on chronic 
morbidity and most of the specific chronic diseases that were selected. Also the sharp 
increase of the sensitivity in function of the number of specific chronic conditions confirms 
the value of this indicator as a global measure of chronic morbidity. 
 
Table 4 indicates that the sensitivity of the global chronic morbidity measure is substantially 
higher among people who assess their subjective health as bad to very bad than among 
those who consider themselves to be in good health. The difference is particularly high for 
persons with hypertension, cataract and glaucoma. It is remarkable that especially those 
diseases show only a weak or no association with self-reported chronic morbidity. These 
findings support the hypothesis that the question on chronic morbidity in a HIS covers more 
the concept of “illness” than the one of “disease”. Illness is defined as the ill health people 
identify themselves with. In contrast, disease is a condition that is defined by a physician, or 
another medical expert (Wikman et al. 2005). It may be that respondents only identify a 
specific chronic disease or condition as a chronic illness if this disease has a clear impact on 
their living situation in terms of suffering or other inconveniences. 
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The subjective component of a global question on chronic morbidity should not be taken in 
a negative way. Subjective judgments should be considered a valid approach to 
measurement. Biases inherent in subjective judgments do not threaten the validity of the 
measurement process: health, or quality of life, is inherently subjective and is as the patient 
perceives it (McDowell et al. 1996). The interpretation of the concept  of chronicity may also 
vary among respondents, albeit that the word “longstanding” is clear enough to assume 
that only diseases are considered with a duration of at least a couple of months. 
 
Unfortunately there are no easy recipes to increase the reliability and validity of a global 
question on chronic morbidity. It is clear that unambiguous and specific questions are more 
reliable and valid than global, less precise questions. Further research should aim to 
increase our understanding on the way in which the concept of chronic morbidity based on 
one global question in a survey relates to objective measures of chronic morbidity. Such 
research should including cognitive testing and physical examinations or linkage with 
chronic disease registers. 
 
Conclusion 
Self-reported chronic morbidity, measured by a single and global question, is a reasonably 
reliable instrument to measure ill health, but for the comparison over time or between 
countries, standardised methods of data collection are essential. The instrument seems to 
underestimate the prevalence of persons with chronic diseases based on medical diagnoses, 
but provides useful information on the burden of disease, because it takes into account the 
relevance of these diseases for the people themselves. This relevance may be related to the 
impact of the disease on their daily living situation in various ways: functional limitations, 
pain, financial and social consequences, etc. Therefore self-reported chronic morbidity 
cannot substitute information on chronic diseases in medical registries, but is 
complementary. The relatively easy way to obtain this type of information is definitely an 
advantage. 
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Table 1 Estimates1 and reliability of a general question on self-reported chronic morbidity in HIS and census, population 
> 14 years, Belgium, 2001 
 
 
      N Prevalence self-reported 
chronic morbidity in HIS 
Prevalence self-reported 
chronic morbidity in census2 Reliability 
  %  (95% CI) %  (95% CI) Kappa (95% CI) 
Gender  
      Men 1,408 28.3 (25.2-31.6) 25.4 (22.0-29.2) 0.562 (0.527-0.598) 
Women 1,463 28.4 (25.1-32.1) 27.2 (23.8-30.8) 0.555 (0.520-0.590) 
Age  
      15-24 yrs 358 12.7 (8.6-18.5) 10.1 (6.3-15.8) 0.456 (0.418-0.494) 
25-44 yrs 1,083 18.2 (15.2-21.8) 13.1 (10.5-16.4) 0.506 (0.469-0.542) 
45-64 yrs 839 32.7 (28.4-37.3) 31.4 (26.9-36.3) 0.540 (0.504-0.576) 
65 + yrs 591 50.4 (43.9-56.9) 54.3 (47.1-61.4) 0.474 (0.437-0.511) 
Self-rated health  
      Very good to good 1,930 15.7 (13.3-18.5) 11.8 (9.5-14.5) 0.367 (0.329-0.407) 
Moderate to bad 658 68.0 (63.0-72.5) 68.4 (63.5-73.0) 0.427 (0.389-0.465) 
GHQ-score  
      0-3 2,197 47.6 (40.1-55.1) 42.1 (34.6-49.9) 0.526 (0.488-0.565) 
4 or more 341 24.7 (22.1-27.6) 22.5 (19.8-25.5) 0.631 (0.596-0.667) 
Education  
      Primary 475 39.4 (32.4-46.9) 49.4 (40.3-58.6) 0.563 (0.527-0.599) 
Lower secondary 569 36.2 (30.3-42.5) 32.8 (26.8-39.3) 0.506 (0.469-0.544) 
Higher secondary 784 23.7 (19.4-28.6) 19.1 (15.4-23.5) 0.590 (0.555-0.625) 
Tertiary 929 21.3 (17.9-25.0) 16.2 (13.1-19.9) 0.523 (0.486-0.560) 
Nationality  
      Belgian 2,591 28.7 (26.1-31.4) 26.7 (23.9-29.8) 0.574 (0.539-0.609) 
Non-Belgian 277 23.4 (17.3-30.9) 20.3 (14.4-27.8) 0.417 (0.379-0.456) 
HIS respondent  
      Selected person 2,755 28.2 (25.7-30.9) 25.8 (23.2-28.5) 0.559 (0.523-0.594) 
Proxy 112 32.3 (19.1-49.2) 39.2 (23.7-57.2) 0.555 (0.519-0.590) 
 
 
      Total 2,871 28.4 (25.9-30.9) 26.3 (23.6-29.2) 0.559 (0.523-0.594) 
1 weighted percentages 
2 calculated among HIS respondents only 
2 
 
 
Table 2 Discrepancy in self-reported chronic morbidity among respondents (> 14 years) participating both in HIS and 
census during the same time period.  Belgium, 2001 (total n* = 2.527) 
 
 
 
% discrepancy 
(95% CI) 
OR inconsistent result versus 
consistent result (95% CI)** 
     Gender 
    Men 18.8 (15.6-22.5) 1.00 
 
Women 17.7 (14.9-20.8) 0.90 (0.66-1.23) 
Age 
    
15-24 yrs 10.7 (6.6-16.8) 1.00 
 
25-44 yrs 13.4 (10.8-16.6) 1.17 (0.64-2.14) 
45-64 yrs 21.4 (17.5-25.9) 1.98 (1.06-3.69) 
65 + yrs 27.2 (20.5-35.0) 2.57 (1.29-5.12) 
Education 
    
Primary 25.6 (17.9-35.1) 1.30 (0.75-2.24) 
Lower secondary 20.7 (16.6-25.6) 1.17 (0.79-1.74) 
Higher secondary 16.2 (12.4-20.9) 0.96 (0.63-1.47) 
Tertiary 14.6 (11.8-17.9) 1.00  
Nationality     
Belgian 17.8 (15.5-20.5) 1.00  
Non-Belgian 23.6 (17.0-31.7) 1.18 (0.70-1.98) 
Self-rated health     
Very good to good 16.3 (13.6-19.5) 1.00 
 
Moderate to bad 24.3 (20.3-28.9) 1.24 (0.83-1.86) 
GHQ-score 
    
0-3 18.4 (15.8-21.3) 1.00 
 
4 or more 16.6 (11.6-23.1) 0.84 (0.50-1.41) 
     
Total 18.2 (16.0-20.7) 
 
 
* proxy interviews not included 
**based on logistic regression adjusted for all other variables in the model 
  
3 
 
Table 3. Outcome of the literature review exploring the specificity of self-reported chronic diseases included in the list 
used in the HIS 2001 and the HIS 2004, compared to a gold standard 
 
Paper 
 
 
Gold standard  
 
Disease
§
 
 
Specificity 
 
 
Ahluwalia IB. Tessaro I. Rye S. Parker L. Self-reported and clinical 
measurement of three chronic disease risks among low-income women in 
West Virginia. J Women's Health 2009;18(11):1857-62. 
 
 
Clinical 
assessment  
 
Hypertension 
 
86.0% 
Bombard JM. Powell KE. Martin LM. Helmick CG. Wilson WH. Validity and 
reliability of self-reported arthritis: Georgia Senior Centers. 2000-2001. 
Am J Prev Med 2005;28(3):251-8. 
 
Clinical 
assessment 
Arthritis 70.3% 
Bowlin SJ. Morrill BD. Nafziger AN. Lewis C. Pearson TA. Reliability and 
changes in validity of self-reported cardiovascular disease risk factors 
using dual response: The behavioral risk factor survey. J Clin Epidemiol 
1996;49(5):511-7. 
 
Clinical 
assessment 
Hypertension 
Diabetes 
84.0% 
98.0% 
Brix TH. Kyvik KO. Hegedus L. Validity of self-reported hyperthyroidism 
and hypothyroidism: Comparison of self-reported questionnaire data with 
medical record review. Thyroid 2001;11(8):769-73. 
 
Medical records Hyperthyroidism 
Hypothyroidism 
57.0% 
67.0% 
Brooks DR. Avetisyan R. Jarrett KM. Hanchate A. Shapiro GD. Pugh MJ. et 
al. Validation of self-reported epilepsy for purposes of community 
surveillance. Epilepsy Behav 2012 Jan;23(1):57-63. 
 
Medical records Epilepsy 99.2% 
Carter K. Barber PA. Shaw C. How does self-reported history of stroke 
compare to hospitalization data in a population-based survey in New 
Zealand? Stroke 2010;41(11):2678-80. 
 
Hospitalisation 
data  
Stroke 98.0% 
Engstad T. Bonaa KH. Viitanen M. Validity of self-reported stroke: The 
Tromso study. Stroke 2000;31(7):1602-7. 
 
Clinical 
assessment 
Stroke 99.0% 
Espelt A. Goday A. Franch J. Borrell C. Validity of self-reported diabetes in 
health interview surveys for measuring social inequalities in the 
prevalence of diabetes. J Epidemiol Community Health 2012;66(7). 
 
Clinical 
assessment 
Diabetes 98.8% 
Fowles JB. Fowler EJ. Craft C. Validation of claims diagnoses and self-
reported conditions compared with medical records for selected chronic 
diseases. J Ambul Care Manage 1998;21(1):24-34. 
 
Medical records Asthma 
Cancer or tumor 
Chronic lung disease 
Diabetes 
Heart trouble or 
angina 
Hypertension 
Liver problems 
Stroke 
Sciatica or chronic 
back problem 
 
99.0% 
96.0% 
98.0% 
100.0% 
97.0% 
 
98.0% 
100.0% 
98.0% 
98.0% 
Giles WH. Croft JB. Keenan NL. Lane MJ. Wheeler FC. The validity of self-
reported hypertension and correlates of hypertension awareness among 
blacks and whites within the stroke belt. Am J Prev Med 1995 
May;11(3):163-9. 
 
Clinical 
assessment 
Hypertension 88.0–91.0% 
Halabi S. Zurayk H. Awaida R. Darwish M. Saab B. Reliability and validity of 
self and proxy reporting of morbidity data: a case study from Beirut. 
Lebanon. Int J Epidemiol 1992 Jun;21(3):607-12. 
 
Clinical 
assessment 
Heart disease 
Hypertension 
Back pain 
 
94.0-97.0% 
81.0-92.0% 
55.0-79.0% 
Jin YP. Di LS. Ostbye T. Feightner JW. Saposnik G. Hachinski V. Is stroke 
history reliably reported by elderly with cognitive impairment? A 
community-based study. Neuroepidemiology 2010;35(3):215-20. 
 
Clinical 
assessment 
Stroke 97.0% 
Linton KLP. Klein BEK. Klein R. The validity of self-reported and surrogate-
reported cataract and age-related macular degeneration in the Beaver 
Dam Eye Study. Am J Epidemiol 1991;134(12):1438-46. 
Clinical 
assessment 
Cataract > 90,0% 
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Paper 
 
 
Gold standard  
 
Disease
§
 
 
Specificity 
 
 
Machon M. Arriola L. Larranaga N. Amiano P. Moreno-Iribas C. Agudo A. et 
al. Validity of self-reported prevalent cases of stroke and acute myocardial 
infarction in the Spanish cohort of the EPIC study. J Epidemiol Community 
Health 2013 Jan;67(1):71-5. 
 
 
Medical records 
 
Stroke 
Acute myocardial 
infarction 
 
 
99.6% 
99.6-99.8% 
Martin LM. Leff M. Calonge N. Garrett C. Nelson DE. Validation of self-
reported chronic conditions and health services in a managed care 
population. Am J Prev Med 2000;18(3):215-8. 
 
Medical records Hypertension 
Diabetes 
81.4% 
99.3% 
Menon C. Gipson K. Bowe WP. Hoffstad OJ. Margolis DJ. Validity of subject 
self-report for acne. Dermatology 2008;217(2):164-8. 
 
Clinical 
assessment 
Acne 72.0% 
Muhajarine N. Mustard C. Roos LL. Young TK. Gelskey DE. Comparison of 
survey and physician claims data for detecting hypertension. J Clin 
Epidemiol 1997 Jun;50(6):711-8. 
 
Clinical 
assessment 
Hypertension 82.6% 
Okura Y. Urban LH. Mahoney DW. Jacobsen SJ. Rodeheffer RJ. Agreement 
between self-report questionnaires and medical record data was 
substantial for diabetes. hypertension. myocardial infarction and stroke 
but not for heart failure. J Clin Epidemiol 2004 Oct;57(10):1096-103. 
Medical records Heart failure 
Diabetes 
Hypertension 
Myocardial Infarction 
Stroke 
 
97.0% 
99.7% 
92.2% 
98.2% 
98.6% 
Patty L. Wu C. Torres M. Azen S. Varma R. Validity of self-reported eye 
disease and treatment in a population-based study: The Los Angeles latino 
eye study. Ophthalmology 2012;119(9):1725-30. 
 
Clinical 
assessment 
Cataract 92.5% 
96.3% 
 
Reitz C. Schupf N. Luchsinger JA. Brickman AM. Manly JJ. Andrews H. et al. 
Validity of self-reported stroke in elderly African Americans. Caribbean 
Hispanics. and Whites. Arch Neurol 2009 Jul;66(7):834-40. 
 
Magnetic 
Resonance 
Imaging (MRI) 
Stroke 78.9% 
Schneider ALC. Pankow JS. Heiss G. Selvin E. Validity and reliability of self-
reported diabetes in the atherosclerosis risk in communities study. Am J 
Epidemiol 2012;176(8):738-43. 
 
Clinical 
assessment 
Diabetes 95.6-96.8% 
Simpson CF. Boyd CM. Carlson MC. Griswold ME. Guralnik JM. Fried LP. 
Agreement between self-report of disease diagnoses and medical record 
validation in disabled older women: factors that modify agreement. J Am 
Geriatr Soc 2004 Jan;52(1):123-7. 
 
Clinical 
assessment 
Parkinson’s disease 
Diabetes mellitus 
Cancer (any) 
Stroke 
Arthritis 
 
100.0% 
99.0% 
98.0% 
97.0% 
45.0% 
Stavrou E. Vajdic CM. Loxton D. Pearson SA. The validity of self-reported 
cancer diagnoses and factors associated with accurate reporting in a 
cohort of older Australian women. Cancer Epidemiol 2011 Dec;35(6):e75-
e80. 
 
Cancer registry Cancer 96.9% 
Taylor A. Grande ED. Gill T. Pickering S. Grant J. Adams R. et al. Comparing 
self-reported and measured high blood pressure and high cholesterol 
status using data from a large representative cohort study. Aust New 
Zealand J Public Health 2010;34(4):394-400. 
 
Clinical 
assessment 
Hypertension >98.0% 
Vargas CM. Burt VL. Gillum RF. Pamuk ER. Validity of self-reported 
hypertension in the National Health and Nutrition Examination Survey III. 
1988-1991. Prev Med 1997;26(5 I):678-85. 
 
Clinical 
assessment 
Hypertension 90.0% 
Wada K. Yatsuya H. Ouyang P. Otsuka R. Mitsuhashi H. Takefuji S. et al. 
Self-reported medical history was generally accurate among Japanese 
workplace population. J Clin Epidemiol 2009;62(3):306-13. 
 
Clinical 
asessment 
Hypertension 
Diabetes 
95.9% 
99.3% 
Yoo KH. Johnson SK. Voigt RG. Campeau LJ. Yawn BP. Juhn YJ. 
Characterization of asthma status by parent report and medical record 
review. J Allergy Clin Immunol 2007;120(6):1468-9. 
 
Medical records Asthma 94.3% 
§
 Only diseases which are included in the Belgian HIS2001 and the HIS2004 are considered 
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Table 4 Sensitivity of the global chronic morbidity measure, by self-rated health, HIS Belgium 2001-20041 
     Proportion (95% CI) 2 
 
Self-rated health Cases True + False - Crude 
Adjusted for age. 
gender and the  
other diseases 3  
Asthma  Good to very good 423 242 181 61.7 (54.7-68.2) 56.9 (50.5-63.3) 
  Moderate to bad 472 381 91 81.5 (76.4-85.7) 83.9 (80.0-87.7) 
   Total 895 623 272 71.6 (67.3-75.5) 69.7 (64.8-74.6) 
         
Hypertension   Good to very good 1,466 482 984 30.2 (27.1-33.5) 27.8 (24.9-30.7) 
  Moderate to bad 1,388 1017 371 72.0 (68.5-75.2) 60.3 (56.1-64.4) 
   Total 2,854 1499 1355 49.9 (47.3-52.6) 40.1 (36.9-43.3) 
         
Serious heart 
disease or 
heart attack 
 Good to very good 258 145 113 58.5 (49.5-66.9) 49.6 (42.3-57.0) 
 Moderate to bad 648 547 101 83.3 (78.2-87.3) 79.5 (74.5-84.5) 
  Total 906 692 214 75.9 (71.6-79.7) 67.4 (61.6-73.1) 
         
Stroke and 
complications 
of stroke 
 Good to very good 35 17 18 63.7 (41.4-81.4) 53.5 (36.8-70.3) 
 Moderate to bad 85 73 12 86.1 (75.0-92.8) 82.0 (71.9-92.0) 
  Total 120 90 30 78.5 (67.5-86.5) 66.0 (52.4-79.7) 
         
Diabetes 
mellitus 
 Good to very good 299 170 129 52.6 (43.0-62.0) 46.2 (38.6-53.9) 
 Moderate to bad 489 411 78 80.1 (74.5-84.7) 77.2 (71.7-82.8) 
   Total 788 581 207 69.5 (63.8-74.6) 61.2 (54.3-68.1) 
         
Epilepsy   Good to very good 43 25 18 61.0 (42.2-77.1) 66.8 (53.2-80.3) 
  Moderate to bad 65 60 5 94.6 (85.7-98.1) 88.8 (82.7-94.9) 
   Total 108 85 23 80.1 (69.1-87.9) 80.2 (70.2-90.2) 
         
Parkinson’s 
disease 
 Good to very good 14 10 4 73.6 (35.2-93.5) 59.0 (34.0-84.1) 
 Moderate to bad 61 57 4 90.4 (72.8-97.1) 85.0 (71.8-98.2) 
   Total 75 67 8 87.2 (72.0-94.7) 75.7 (57.4-94.1) 
         
Cataract  Good to very good 226 97 129 40.4 (32.0-49.3) 36.0 (28.7-43.4) 
  Moderate to bad 344 281 63 81.2 (74.7-86.3) 69.0 (61.9-76.0) 
   Total 570 378 192 65.0 (59.2-70.3) 48.0 (40.4-55.5) 
         
Glaucoma   Good to very good 192 77 115 36.2 (26.8-46.8) 32.8 (25.4-40.1) 
  Moderate to bad 275 218 57 77.3 (69.6-83.5) 65.8 (58.2-73.4) 
   Total 467 295 172 57.2 (50.1-64.1) 44.7 (36.7-52.6) 
         
Cancer 
  
 Good to very good  84 50 34 63.9 (47.2-77.8) 52.0 (40.9-63.0) 
 Moderate to bad 210 180 30 82.1 (72.4-88.9) 81.0 (74.1-87.9) 
    Total 294 230 64 76.6 (68.8-82.9) 69.5 (61.4-77.6) 
1 proxy interviews not included 
2 weighted proportions, taking into account the survey design effects 
3 adjustment based on a logistic regression model including age. gender and the listed diseases
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Table 5 Factors associated with the sensitivity of the global chronic morbidity measure§,  results from a logistic 
regression analysis – Health Interview Survey Belgium, 2001-2004 (total n = 4.090) 
 
Factor 
 
OR (95% CI) 
 
Gender (reference: men) 
Women 
 
  
 
0.86 
 
 
(0.72-1.03) 
 
Age (reference:  15-24 yrs) 
25-44 yrs 
45-64 yrs 
65 + yrs 
 
  
1.27 
1.17 
1.43 
 
 
(0.74-2.20) 
(0.70-1.94) 
(0.85-2.40) 
 
Education (reference : tertiary) 
Primary 
Lower secondary 
Higher secondary 
 
  
0.81 
0.88 
0.87 
 
 
(0.61-1.08) 
(0.67-1.16) 
(0.67-1.13) 
 
Nationality (reference: Belgian) 
Non-Belgian 
 
  
0.60 
 
 
(0.41-0.86) 
 
Self-rated health (reference: very good to good)  
Moderate to bad 
 
  
3.85 
 
(3.17-4.69) 
 
GHQ-score (reference : 0-3) 
4 or more 
 
  
1.34 
 
 
(1.02-1.75) 
 
Year (reference: 2001) 
 2004 
 
  
0.93 
 
(0.77-1.13) 
Disease (reference: absence of indicated disease) 
 Asthma 
 Hypertension 
 Serious heart disease or heart attack 
 Stroke 
 Diabetes 
 Epilepsy 
 Parkinson’s disease 
 Cataract 
 Glaucoma 
 Cancer 
  
3.25 
0.99 
2.50 
2.98 
2.30 
4.70 
3.30 
1.42 
1.24 
2.74 
 
(2.39-4.42) 
(0.79-1.26) 
(1.85-3.36) 
 (1.53-5.81) 
 (1.69-3.11) 
 (2.41-9.16) 
(1.18-9.27) 
(1.02-1.97) 
(0.89-1.72) 
(1.69-4.44) 
   
§Suffering from at least one of the following specific chronic diseases: asthma, serious heart diseases, 
hypertension, stroke, cancer, diabetes , Parkinson’s disease, epilepsy, cataract, glaucoma  
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Figure 1 Sensitivity of the global chronic morbidity measure in function of the number of reported specific chronic 
diseases 
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Results 
 
The original version of this article unfortunately contained a mistake. The prevalences reported by GHQ-score category 
in Table 1 were swabbed. The corrected Table 1 is given below.  
 
Table 1 Estimates1 and reliability of a general question on self-reported chronic morbidity in HIS and census, population 
> 14 years, Belgium, 2001 
 
 
      N Prevalence self-reported 
chronic morbidity in HIS 
Prevalence self-reported 
chronic morbidity in census2 Reliability 
  %  (95% CI) %  (95% CI) Kappa (95% CI) 
Gender  
      Men 1,408 28.3 (25.2-31.6) 25.4 (22.0-29.2) 0.562 (0.527-0.598) 
Women 1,463 28.4 (25.1-32.1) 27.2 (23.8-30.8) 0.555 (0.520-0.590) 
Age  
      15-24 yrs 358 12.7 (8.6-18.5) 10.1 (6.3-15.8) 0.456 (0.418-0.494) 
25-44 yrs 1,083 18.2 (15.2-21.8) 13.1 (10.5-16.4) 0.506 (0.469-0.542) 
45-64 yrs 839 32.7 (28.4-37.3) 31.4 (26.9-36.3) 0.540 (0.504-0.576) 
65 + yrs 591 50.4 (43.9-56.9) 54.3 (47.1-61.4) 0.474 (0.437-0.511) 
Self-rated health  
      Very good to good 1,930 15.7 (13.3-18.5) 11.8 (9.5-14.5) 0.367 (0.329-0.407) 
Moderate to bad 658 68.0 (63.0-72.5) 68.4 (63.5-73.0) 0.427 (0.389-0.465) 
GHQ-score  
      0-3 2,197 24.7 (22.1-27.6) 22.5 (19.8-25.5) 0.526 (0.488-0.565) 
4 or more 341 47.6 (40.1-55.1) 42.1 (34.6-49.9) 0.631 (0.596-0.667) 
Education      
  Primary 475 39.4 (32.4-46.9) 49.4 (40.3-58.6) 0.563 (0.527-0.599) 
Lower secondary 569 36.2 (30.3-42.5) 32.8 (26.8-39.3) 0.506 (0.469-0.544) 
Higher secondary 784 23.7 (19.4-28.6) 19.1 (15.4-23.5) 0.590 (0.555-0.625) 
Tertiary 929 21.3 (17.9-25.0) 16.2 (13.1-19.9) 0.523 (0.486-0.560) 
Nationality  
      Belgian 2,591 28.7 (26.1-31.4) 26.7 (23.9-29.8) 0.574 (0.539-0.609) 
Non-Belgian 277 23.4 (17.3-30.9) 20.3 (14.4-27.8) 0.417 (0.379-0.456) 
HIS respondent  
      Selected person 2,755 28.2 (25.7-30.9) 25.8 (23.2-28.5) 0.559 (0.523-0.594) 
Proxy 112 32.3 (19.1-49.2) 39.2 (23.7-57.2) 0.555 (0.519-0.590) 
 
 
      Total 2,871 28.4 (25.9-30.9) 26.3 (23.6-29.2) 0.559 (0.523-0.594) 
1 weighted percentages 
2 calculated among HIS respondents only 
